Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | HTR5A | P47898 | 1/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 5/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 5/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.33 |
| ▸ | TUBB | P07437 | 1/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.33 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4657348 | 0.74 | ALDH1A1 (0.48) | ALDH1A1KDM4EHSD17B10TSHRHTR2C | |
| SCHEMBL2355429 | 0.72 | ALDH1A1 (0.50) | ALDH1A1KDM4EHSD17B10TSHRHTR2C | |
| SCHEMBL29536407 | 0.72 | ALDH1A1 (0.50) | ALDH1A1KDM4EHSD17B10TSHRHTR2C | |
| SCHEMBL11484541 | 0.70 | ALDH1A1 (0.48) | ALDH1A1KDM4EHSD17B10TSHRHTR2C | |
| SCHEMBL7904037 | 0.70 | AHR (0.42) | ALDH1A1KDM4EHSD17B10TSHRHTR2C | |
| SCHEMBL254822 | 0.69 | KDM4E (0.46) | ALDH1A1KDM4EHSD17B10TSHRMAPK1 | |
| SCHEMBL4657344 | 0.69 | EPHB4 (0.40) | ALDH1A1KDM4EHSD17B10TSHRHTR2C | |
| SCHEMBL7713840 | 0.69 | ALDH1A1 (0.43) | ALDH1A1KDM4EHSD17B10TSHRHTR2C | |
| SCHEMBL13843510 | 0.69 | CYP2A6 (0.48) | ALDH1A1KDM4EHSD17B10TSHRMAPK1 | |
| SCHEMBL10945599 | 0.68 | ALDH1A1 (0.47) | ALDH1A1KDM4EHSD17B10TSHRHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1636243-B1 | CHIRAL LIGANDS FOR APPLICATION IN ASYMMETRIC SYNTHESES | BOEHRINGER INGELHEIM INT (DE) | 2013-11-06 | — | — | EP | disclosed |
| US-7396947-B2 | Chiral ligands for application in asymmetric syntheses | LANXESS DEUTSCHLAND GMBH (DE) | 2008-07-08 | — | — | US | disclosed |
| US-20070004927-A1 | Chiral ligands for application in asymmetric syntheses | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20060161022-A1 | Chiral ligands for application in asymmetric syntheses | LANXESS DEUTSCHLAND GMBH (DE) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004927-A1 | Chiral ligands for application in asymmetric syntheses | COASY, SPR, DHPS | ALDH1A1 348/4885KDM4E 4280/4885HSD17B10 178/4885 |
| US-20060161022-A1 | Chiral ligands for application in asymmetric syntheses | COASY, SPR, DHPS | ALDH1A1 348/4885KDM4E 4280/4885HSD17B10 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.